Healthpeak Properties (US.DOC)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.DOC · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 100.0% | → |
| ROE | 2.5% | ↑ |
| Cash Conversion | 134.8% | ↓ |
| D/E Ratio | 1.37 | ↓ |
| Gross Margin | 57.0% | ↓ |
US.DOC (Healthpeak Properties) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 100.0% → ROE 2.5% ↑ Cash Conversion 134.8% ↓ D/E Ratio 1.37 ↓ Gross Margin 57.0% ↓
Key Metrics
US.DOC (Healthpeak Properties) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 100.0% →ROE 2.5% ↑Cash Conversion 134.8% ↓D/E Ratio 1.37 ↓Gross Margin 57.0% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies